| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 177.612 | 221.573 | 141.480 | 128.827 | 139.674 | 149.650 | 148.075 |
| Total Income - EUR | - | - | 0 | 288.965 | 352.250 | 205.766 | 206.693 | 225.147 | 267.335 | 221.527 |
| Total Expenses - EUR | - | - | 840 | 265.667 | 320.749 | 199.991 | 274.473 | 262.899 | 264.243 | 229.177 |
| Gross Profit/Loss - EUR | - | - | -840 | 23.298 | 31.500 | 5.775 | -67.779 | -37.752 | 3.092 | -7.650 |
| Net Profit/Loss - EUR | - | - | -840 | 21.479 | 29.355 | 4.825 | -68.737 | -39.203 | 1.315 | -7.650 |
| Employees | - | - | 0 | 8 | 5 | 6 | 6 | 6 | 5 | 5 |
Check the financial reports for the company - Nadocarm Alim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 49.207 | 42.699 | 35.208 | 29.491 | 23.331 | 17.778 | 11.059 |
| Current Assets | - | - | 453 | 42.647 | 55.048 | 58.092 | 28.787 | 25.381 | 26.998 | 25.163 |
| Inventories | - | - | 366 | 22.230 | 31.240 | 43.971 | 11.135 | 5.779 | 10.434 | 5.180 |
| Receivables | - | - | 0 | 4.959 | 4.089 | 5.962 | 14.806 | 16.957 | 9.682 | 12.902 |
| Cash | - | - | 86 | 15.458 | 19.718 | 8.159 | 2.846 | 2.645 | 6.882 | 7.081 |
| Shareholders Funds | - | - | -796 | 20.697 | 49.330 | 53.222 | -22.705 | 1.896 | 3.205 | -4.463 |
| Social Capital | - | - | 44 | 43 | 42 | 43 | 42 | 43 | 63.724 | 63.368 |
| Debts | - | - | 1.249 | 31.807 | 15.380 | 11.958 | 58.521 | 29.110 | 31.250 | 35.562 |
| Income in Advance | - | - | 0 | 40.174 | 34.147 | 28.350 | 22.686 | 17.706 | 12.617 | 7.539 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1013 - 1013" | |||||||||
| CAEN Financial Year |
1013
|
|||||||||
Comments - Nadocarm Alim Srl